Search Results

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Sarah Cannon Research Institute
Apr 2, 2024, 12:12 | Positive
Vivek Subbiah: His incredible leadership is providing strategic vision for Banner Health
Vivek Subbiah shared a post on LinkedIn: “So nice catching up with my great friend…
Mar 29, 2024, 17:36 | Positive
Vivek Subbiah: On Doctors' Day, feeling blessed to receive hugs from my patients
Vivek Subbiah shared a post on LinkedIn: "Happy Doctors' Day to all the incredible healthcare…
Mar 25, 2024, 15:56 | Blog
Vivek Subbiah: Such a delight to host a JAMA Oncology podcast interview with Tobias Janowitz and Karen Winkfield
Vivek Subbiah recently posted on X: “Such a delight to host a JAMA Oncology podcast…
Mar 25, 2024, 06:01 | Insight
Vivek Subbiah: For patients with NSCLC, initial use of SGT increases subsequent CGP test cancellations
Vivek Subbiah recently posted on X: "Just published in time for the ELCC24: The Impact of…
Mar 24, 2024, 00:09 | Blog
Vivek Subbiah: Tune in to the podcast for insights into equitable access to cancer clinical trials
Vivek Subbiah posted on LinkedIn “Excited to announce my latest venture! Hosting an interview with…
Mar 22, 2024, 05:19 | Blog
Erika Hamilton: 100 cycles on a phase I clinical trial for metastatic disease - THIS is why we do clinical trials
Erika Hamilton and Vivek Subbiah shared a post by Sarah Cannon Research Institute: "Several years ago,…
Mar 21, 2024, 09:58 | Blog
Vivek Subbiah: Presenting the story of Hydra and Cancer
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute in the…
Mar 19, 2024, 20:14 | Blog
Vivek Subbiah: Nice to see CAR-T cells showing early signals of activity in Glioblastoma in a Phase 1
Vivek Subbiah shared a post on LinkedIn: "Nice to see CAR-T cells showing early signals of…
Mar 19, 2024, 03:22 | Blog
Vivek Subbiah: Exceptional Responses to Selpercatinib in RET Fusion–Driven Metastatic Pancreatic Cancer
Vivek Subbiah shared a post on X/Twitter: ''Exceptional Responses to Selpercatinib in RET Fusion–Driven Metastatic…
Mar 18, 2024, 15:28 | Blog
Vivek Subbiah: Universal germline, in addition to tumor somatic, genomic testing is needed to win the war against cancer
Vivek Subbiah recently shared a post on X/Twitter: “Pleased to share Universal Germline and Tumor…
All: 445 Posts: 291 - 300
Special Coverage